PURE BIOSCIENCE, INC. (PURE)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Jul 31
In fiscal 2025, PURE BIOSCIENCE, INC. reported revenue of $2.20M, up 12.2% from the prior year. The company ran a net loss, with a net margin of -108.9% and a gross margin of 59.2%. It held $1.06M in total assets against $6.17M in total liabilities.
Key ratios (FY2025)
59.2%
Gross margin
-103.2%
Operating margin
-108.9%
Net margin
+12.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.20M | $1.96M | $1.88M | $1.85M | $3.93M | $6.92M | $1.91M | $1.77M | $1.83M | — |
| Cost of Revenue | $899.0K | $811.0K | $906.0K | $853.0K | $1.85M | $2.90M | $728.0K | $763.0K | $760.0K | — |
| Gross Profit | $1.30M | $1.15M | $971.0K | $1.00M | $2.08M | $4.02M | $1.18M | — | — | — |
| Operating Income | -$2.27M | -$3.19M | -$3.94M | -$3.72M | -$2.31M | $4.0K | -$5.59M | -$7.04M | -$6.01M | -$7.06M |
| Net Income | -$2.40M | -$3.35M | -$3.96M | -$3.49M | -$2.32M | $4.0K | -$6.55M | -$7.44M | -$6.26M | -$14.37M |
| EPS (Diluted) | $-0.02 | $-0.03 | $-0.04 | $-0.04 | $-0.03 | $0.00 | $-0.09 | — | — | — |
| Total Assets | $1.06M | $818.0K | $1.82M | $4.48M | $4.30M | $6.32M | $1.93M | $2.58M | $3.83M | $7.56M |
| Total Liabilities | $6.17M | $3.68M | $1.55M | $575.0K | $970.0K | $1.51M | $742.0K | $1.29M | $2.54M | $2.54M |
| Shareholders' Equity | -$5.12M | -$2.86M | $272.0K | $3.91M | $3.33M | $4.81M | $1.19M | $1.28M | $1.29M | $5.02M |
| Cash & Equivalents | $334.0K | $349.0K | $1.09M | $3.39M | $2.39M | $3.84M | $398.0K | $851.0K | $1.64M | $5.19M |
| Operating Cash Flow | -$2.02M | -$2.53M | -$3.28M | -$2.42M | -$1.17M | $669.0K | -$2.99M | -$3.89M | -$4.56M | -$4.99M |
| Capital Expenditures | — | — | $33.0K | $81.0K | $521.0K | $58.0K | $7.0K | $19.0K | $206.0K | $390.0K |
| Shares Outstanding | 111.89M | 111.86M | 111.86M | 111.36M | 87.22M | 87.07M | 76.73M | 68.25M | 63.09M | 64.82M |